All subjects
Biochemicals & Materials

Avantium and Will & Co deepen collaboration with FDCA capacity reservation

Avantium and Will & Co deepen collaboration with FDCA capacity reservation
Biobased furandicarboxylic acid (FDCA) is a versatile, bio-based building block used in synthetic materials, including alkyd resins, surfactants, and polyester polyols with potential applications in the Coatings, Adhesives, Sealants and Elastomers (CASE) industry (photo courtesy Avantium).

In the Netherlands, Avantium N.V., a leader in renewable and circular polymer materials, and Will & Co B.V., a distributor of specialty (bio-based) chemicals, have deepened their collaboration by signing a capacity reservation agreement for furandicarboxylic acid (FDCA) from future licensed production capacity.

According to a statement, the agreement reflects Will & Co’s interest in securing future access to FDCA for applications in the Coatings, Adhesives, Sealants and Elastomers (CASE) markets and builds on their February 2026 collaboration to accelerate FDCA development and adoption in the CASE industry.

FDCA is a versatile, bio-based building block used in synthetic materials, including alkyd resins, surfactants, and polyester polyols, with potential applications ranging from paints and adhesives to flooring, roofing, tubing, automotive components, and construction materials.

The capacity reservation marks a further step towards the potential commercialization of these applications.

Continue joint-development activities

Under the agreement, Will & Co has expressed its interest in reserving future FDCA capacity from plants operated by licensees of Avantium’s “YXY Technology”.

Avantium intends to introduce Will & Co to prospective licensees and facilitate discussions on securing capacity, subject to final agreement between Will & Co and the relevant licensee.

For prospective licensees, capacity reservations provide greater visibility on potential demand for the output of future FDCA plants.

This capacity reservation reflects our confidence in the potential of FDCA in the CASE markets. Since starting our collaboration with Avantium, we have continued to explore promising applications for this renewable building block. Reserving future capacity is a logical next step as we work towards bringing FDCA-based solutions to our customers and the wider market, commented Jacques van Lindonk, Managing Director at Will & Co.

By building commercial demand ahead of new production capacity, Avantium aims to help de-risk the business case for prospective licensees, thereby supporting investment in future FDCA production capacity.

In parallel, Avantium and Will & Co will continue their development activities to further advance FDCA applications in the CASE market, with Avantium providing FDCA for this work, alongside technical expertise and other relevant support.

This capacity reservation shows how Avantium’s collaboration with Will & Co is progressing from application development toward commercialization. It demonstrates tangible market interest in FDCA for CASE applications, while supporting our strategy to license our YXY Technology to partners around the world. Building visibility on commercial demand helps strengthen the investment case for prospective licensees and, ultimately, supports the development of new FDCA production capacity, said Marco Jansen, CCO at Avantium.

Most read on Bioenergy International

Get the latest news about Bioenergy

Subscribe for free to our newsletter
Sending request
I accept that Bioenergy International stores and handles my information.
Read more about our integritypolicy here